bioAffinity Technologies (BIAFW) Other Non-Current Assets (2021 - 2026)

bioAffinity Technologies has disclosed Other Non-Current Assets across 6 years of filings, most recently posting $12816.0 for Q1 2026.

• In Q1 2026, Other Non-Current Assets fell 34.86% year-over-year to $12816.0; the TTM figure through Mar 2026 stood at $12816.0 (down 34.86% YoY), while the FY2025 annual figure was $12815.0, down 34.87% from the prior year.
• Other Non-Current Assets was little changed at $12816.0 in Q1 2026, from $12815.0 in the prior quarter.
• Over the last five years, Other Non-Current Assets for BIAFW reached as high as $19676.0 in Q3 2024 and fell as low as $6000.0 in Q3 2022.
• The 5-year median for Other Non-Current Assets is $12816.0 (2026), against an average of $13598.8.
• Annual changes were most pronounced in 2024 — Other Non-Current Assets surged 184.32% — and 2025, when it slumped 34.87%.
• A 5-year view of Other Non-Current Assets shows it stood at $6000.0 in 2022, then soared by 167.67% to $16060.0 in 2023, then rose by 22.52% to $19676.0 in 2024, then plunged by 34.87% to $12815.0 in 2025, then rose by 0.01% to $12816.0 in 2026.
• According to Business Quant data, Other Non-Current Assets over the past three periods registered $12816.0, $12815.0, and $12815.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.